2026 NPPES data Oncology Clinical Nurse Specialist NPI 1538543020
Verify on CMS →

SULIAT ADELEKAN

Oncology Clinical Nurse Specialist in NEW YORK, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
201
Medicare Part D claims · 63 beneficiaries · Oncology Clinical Nurse Specialist avg: 435

What the federal data shows

SULIAT ADELEKAN filed 201 Medicare Part D claims in 2023 as a Oncology Clinical Nurse Specialist in NEW YORK, New York.

201
Part D claims, 2023

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

SULIAT ADELEKAN's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

201 49th percentile higher than 49% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). This entry sits in this band. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

What does the federal data show about SULIAT ADELEKAN?

Quality data not reported

NPI registry status

Active

Issued 07/14/2015

NPI 1538543020

Primary specialty

Oncology Clinical Nurse Specialist

Rare

209 US NPIs in this specialty

Medicare Part D claims

201 54% vs specialty avg

2023 prescription claims

Specialty avg: 435

Specialty distribution in New York

How Oncology Clinical Nurse Specialist compares to other specialties among New York providers

New York providers

Oncology Clinical Nurse Specialist share within New York

1. Oncology Clinical Nurse Specialist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Oncology Clinical Nurse Specialist share within New York

Specialty board-certification context

Estimated specialty board-certified rate — Oncology Clinical Nurse Specialist (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Oncology Clinical Nurse Specialist ABMS/AOA estimate

Est. board-certified rate (Oncology Clinical Nurse Specialist) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Oncology Clinical Nurse Specialist) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

SULIAT ADELEKAN appears in the CMS NPPES registry as a Oncology Clinical Nurse Specialist provider at 1184 5TH AVE, NEW YORK, NY, 10029, with a listed phone of (347) 622-2346. NPI 1538543020 was issued on 07/14/2015. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what ADELEKAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 201 prescription claims written by this provider, covering 63 Medicare beneficiaries and totaling roughly $9K in drug spend. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Oncology Clinical Nurse Specialist is a narrow specialty nationwide, with 209 enrolled providers across 38 states and an average of 435 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1184 5TH AVE
NEW YORK, NY 10029

Provider Details

NPI 1538543020
Specialty Oncology Clinical Nurse Specialist
Gender Female
NPI Issued 07/14/2015

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to SULIAT ADELEKAN. To verify SULIAT ADELEKAN's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

201
Total Claims
$9K
Total Drug Cost
63
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
367
Total Day Supply
10,972
Generic Drug Cost
$4K

Patient Demographics

Average Patient Age
73.7 years
Avg HCC Risk Score
1.62
Gender Split
0% female / 100% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Tamsulosin Hcl
174

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Oncology Clinical Nurse Specialist Overview

How SULIAT ADELEKAN fits within the Oncology Clinical Nurse Specialist landscape nationally.

209
Oncology Clinical Nurse Specialist Providers in US
38
States with Oncology Clinical Nurse Specialist
435
Avg Claims per Provider

SULIAT ADELEKAN's 201 claims are below the specialty average of 435.

Nearby Oncology Clinical Nurse Specialist Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as ADELEKAN.

Compare Oncology Clinical Nurse Specialist nationally: see state-by-state distribution →

Frequently Asked Questions

What is SULIAT ADELEKAN's specialty?
SULIAT ADELEKAN specializes in Oncology Clinical Nurse Specialist and practices in NEW YORK, New York.
How much does SULIAT ADELEKAN prescribe under Medicare Part D?
In 2023, SULIAT ADELEKAN wrote 201 Medicare Part D claims totaling $9K in drug costs for 63 beneficiaries.
Where is SULIAT ADELEKAN located?
SULIAT ADELEKAN is located at 1184 5TH AVE, NEW YORK, NY, 10029. Phone: (347) 622-2346.
What is SULIAT ADELEKAN's NPI number?
SULIAT ADELEKAN's National Provider Identifier (NPI) is 1538543020, issued on 07/14/2015.
How many Oncology Clinical Nurse Specialist providers are there in the US?
There are 209 Oncology Clinical Nurse Specialist providers across 38 states in the US. The average Oncology Clinical Nurse Specialist provider writes 435 Medicare Part D claims per year.
What drugs does SULIAT ADELEKAN prescribe most often?
Based on 2023 Medicare Part D data, SULIAT ADELEKAN's most frequently prescribed drugs include Tamsulosin Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does SULIAT ADELEKAN accept Medicare?
SULIAT ADELEKAN appears in CMS Medicare data with 201 Part D claims and 63 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify SULIAT ADELEKAN's credentials?
SULIAT ADELEKAN's NPI is 1538543020. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology